Rhumatologie : recherche actuelle

Rhumatologie : recherche actuelle
Libre accès

ISSN: 2161-1149 (Printed)


Bone Mineral Density in Patients with Type 2 Diabetes Mellitus Patients

Abdulsatar J Mathkhor1*, Abdulnasser H Abdullah2

Introduction: It is well-documented that type 1 diabetes mellitus shows decreased Bone Mass Density (BMD). Type 2 Diabetes Mellitus (T2DM) affects bone metabolism, but the relationship between T2DM and BMD remains controversial. This study aimed to evaluate the difference in BMD between diabetic and non-diabetic individuals.

Materials and methods: A total of 150 (50 male and 100 female) diabetic patients and 150 (55 male and 95 females) controls with a mean age of 58 ± 6.5 and 59 ± 7.8, respectively, were enrolled for the study. They underwent BMD measurement for the lumbar spine and left femoral neck through Dual-energy X-ray Absorptiometry (DXA) for the presence of osteoporosis according to the WHO criteria. The fasting plasma glucose level of all participants was measured.

Results: Of the 150 diabetic patients there were 11(7.33%), and 21 (14.0%) have osteoporosis and osteopenia in the lumbar spine, respectively, compared to 35 (23.33%) and 48(32.0%) in the non-diabetic group. There were 9(6.0%) and 17(11.33%) had osteoporosis and osteopenia in the left femoral neck in the diabetics, respectively, compared to 27(18.66%) and 42(28.0%) in the non-diabetics.

Conclusion: Patients with T2DM have higher BMD levels when compared to non-diabetics.